Physician profile
Candi Jump
NPI 1063672475
$43,394.93
in general payments reported to CMS, 2019-2025
6 companies · $19K in 2025
The $19K reported for 2025 was more than what 96% of Pediatric Gastroenterology providers received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $429 · 2020: $91.24 · 2021: $12.59 · 2024: $24K · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $32K · Consulting Fee: $6,575 · Travel and Lodging: $3,457 · Food and Beverage: $930.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $31,900.00 |
| Consulting Fee | $6,575.00 |
| Travel and Lodging | $3,457.46 |
| Food and Beverage | $929.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcresta Therapeutics, INC. | $42,842.62 | 2024-2025 | Relizorb |
| Abbvie INC. | $316.42 | 2019-2021 | |
| Janssen Scientific Affairs, LLC | $214.92 | 2019 | |
| Genzyme Corporation | $19.41 | 2025 | |
| Travere Therapeutics, INC. | $1.56 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Candi Jump listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.